Read more

January 18, 2023
32 min listen
Save

Making Sense of Sensory Ganglionopathies, Part 2

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In this episode, Benjamin Claytor, MD, walks us through his approach to suspected sensory ganglionopathies. I also cover other neurologic complications of Sjogren’s syndrome and some interesting history on vitamin B6.

  • Intro 0:12
  • In this episode 0:46
  • Neurologic complications of Sjogren’s Syndrome 1:55
  • Intro of Dr. Benjamin Claytor 6:00
  • The interview 6:49
  • Case study: process of diagnosis 7:17
  • Dorsal root ganglion in Sjogren’s 10:46
  • Facial numbness in sensory ganglionopathies 11:42
  • Dorsal root ganglion biopsies 13:36
  • Prognosis of sensory ganglionopathies vs other distal neuropathies 14:03
  • Sensory loss and weakness 15:51
  • Sensory ataxia 16:24
  • Attacks on the dorsal root ganglion 18:25
  • Loss of fibers in the dorsal root ganglion and regrowth 19:21
  • Treating cancer and sensory ganglionopathies 20:03
  • Idiopathic patients and treatments 20:45
  • Interview wrap-up 21:43
  • Pearls of wisdom from the interview 22:11
  • History of sensory ganglionopathies 23:35
  • Thanks 29:09

Disclosures: Brown and Claytor report no relevant financial disclosures.

Benjamin Claytor, MD, is assistant professor of neurology at the Neuromuscular Center at Cleveland Clinic.

We’d love to hear from you! Send your comments/questions to Dr. Brown at rheuminationspodcast@healio.com. Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum.

References:

Antopol W, et al. J Neuropathol Exp. 1942;doi:10.1097/00005072-194207000-00006.

Pavlakis PP, et al. J Autoimmun. 2012;doi:10.1016/j.jaut.2012.01.003.

Schaumburg H, et al. N Engl J Med. 1983;doi:10.1056/NEJM198308253090801.

Sources/Disclosures

Collapse

Disclosures: Brown and Claytor report no relevant financial disclosures.